FDA terminates emergency use authorization of hydroxychloroquine for Covid-19

gwb-trading · Jul 3, 2020

Dr. Love said:
CNN Has Slammed the Usage of Hydroxychloroquine for Months — Until it Reversed Course In An Early Morning Tweet

By Ben Wilson

After months of claiming hydroxychloroquine is linked to a “greater risk of death” and “doesn’t work,” CNN admitted — at 4 am on the Friday before a holiday — that the drug is linked to significantly higher survival rates in hospitals.

The quietly-announced new study by the Henry Ford Health System in Michigan questions the months of anti-hydroxychloroquine coverage showing that of the 2,541 patients observed, 26 percent of patients not given the drug died, compared to 13 percent of those who did receive hydroxychloroquine.

The research — which is “surprising” according to CNN — was a multi-center retrospective observational study. The full results found that “overall crude mortality rates were 18.1% in the entire cohort, 13.5% in the hydroxychloroquine alone group, 20.1% among those receiving hydroxychloroquine + azithromycin, 22.4% among the azithromycin alone group, and 26.4% for neither drug,” according to the team’s study.

The controversial anti-malaria drug, often touted by President Donald Trump as a potentially effective remedy for COVID-19, was mocked by CNN and other news agencies since mid-March when President Trump began pushing it — and admitting he takes it daily. The Washington Post claimed it was a “false hope” and the Philadelphia Inquirer said it was “the most disappointing, disavowed drug that researchers keep studying for COVID-19.”

CNN wrote in it’s middle-of-the-night discovery that “it’s a surprising finding because several other studies have found no benefit from hydroxychloroquine, a drug originally developed to treat and prevent malaria.”

“President Donald Trump touted the drug heavily, but later studies found not only did patients not do better if they got the drug, they were more likely to suffer cardiac side effects,” CNN said in this morning’s article.

CEO of the Henry Ford Medical Group Dr. Steven Kalkanis, said “It’s important to note that in the right settings, this potentially could be a lifesaver for patients.”

Dr. Marcus Zervos, division head of infectious disease for Henry Ford Health System, said in a news conference that “our results do differ from some other studies.” He noted an important factor is beginning treatment early.

“For hydroxychloroquine to have a benefit, it needs to begin before the patients begin to suffer some of the severe immune reactions that patients can have with Covid,” Zervos told the press.

Peter Navarro, the White House trade adviser, told CNN that “this is a big deal.”

“This medicine can literally save tens of thousands, perhaps hundreds of thousands of American lives and maybe millions of people worldwide,” Navarro said.

With this study shattering previous thought and talking points, perhaps a treatment or highly effective remedy can soon become available — with politics aside.
More...

CNN is merely reporting the news. They are not taking a position.

Buy1Sell2 · Jul 3, 2020

gwb-trading said:
CNN is merely reporting the news. They are not taking a position.
More...

OMG

Dr. Love · Jul 3, 2020

This could have saved tens of thousands of lives.

For the inside scoop, here is Navarro this AM:

Queued.

Tsing Tao · Jul 3, 2020

gwb-trading said:
CNN is merely reporting the news. They are not taking a position.
More...

Right, because it's not like them to ever take a position.

Report the news. CNN. What a laugh riot.

gwb-trading · Jul 5, 2020

WHO halts hydroxychloroquine trials after failure to reduce death
https://thehill.com/policy/healthca...oroquine-trials-after-failure-to-reduce-death

The World Health Organization (WHO) announced Saturday it is halting its trials of the malaria drug hydroxychloroquine and HIV treatment lopinavir-ritonavir in patients hospitalized with the coronavirus after results showed the drugs did not reduce mortality rates.

“These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect,” the WHO said in a statement, referencing multicountry trials it is conducting.

The group, a United Nations agency, said it was ending the tests on the recommendation of the drug trial’s international steering committee. The pause does not impact other studies in which the drugs are used for patients who are not hospitalized.

(More at above url)

Cuddles · Jul 30, 2021

What is the GQP's latest positioning on their miracle Messiah cure?

Buy1Sell2 · Jul 30, 2021

Cuddles said:
What is the GQP's latest positioning on their miracle Messiah cure?
More...

Works extremely well by nearly all accounts.